ArticleThe World Allergy Organization journal2020

Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.